✦ LIBER ✦

A potent sorbitol dehydrogenase inhibitor exacerbates sympathetic autonomic neuropathy in rats with streptozotocin-induced diabetes

✍ Scribed by Robert E. Schmidt; Denise A. Dorsey; Lucie N. Beaudet; Curtis A. Parvin; Kevin E. Yarasheski; Samuel R. Smith; Joseph R. Williamson; Richard G. Peterson; Peter J. Oates

Book ID: 116458476
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 830 KB
Volume: 192
Category: Article
ISSN: 0014-4886
DOI: 10.1016/j.expneurol.2004.12.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Empagliflozin, a novel potent and select

Empagliflozin, a novel potent and selective SGLT-2 inhibitor, improves glycaemic control alone and in combination with insulin in streptozotocin-induced diabetic rats, a model of type 1 diabetes mellitus

✍ G. Luippold; T. Klein; M. Mark; R. Grempler 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 701 KB

Effect of long-term treatment with a new

Effect of long-term treatment with a new aldose reductase inhibitor, (2S,4S)-6-fluoro-2′,5′-dioxospiro-[chroman-4,4′-imidazolidine]-2-carboxamide (SNK-860), on peripheral neuropathy in streptozotocin-induced diabetic rats

✍ Noriaki Kato; Kuniharu Mizuno; Akira Matsubara; Kazumasa Nakano; Masayasu Kurono 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 725 KB